CFDE Data Portal | Search LIPT2-AS1

	Label	Description
	LIPT2-AS1 Gene (Entity type)	ENSG00000254837 - LIPT2 antisense RNA 1
	GSE195663 cisplatin 7 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE144443 0 V 6 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680,GSE182683 7 V 2 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE74490 0 V 1 TRIPTOLIDE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE207499 sphingosine 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155987 LMTK2 knockdown CFBE41o- 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158834 ADIPOR2 knockout HEK293 12 v 13 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE244730 erlotinib PC-9 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS

LIPT2-AS1

ENSG00000254837 - LIPT2 antisense RNA 1

GSE195663 cisplatin 7 v 1 human dn

A Gene Set from LINCS

GSE144443 0 V 6 NICOTINAMIDE MOUSE UP

A Gene Set from LINCS

GSE182680,GSE182683 7 V 2 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

GSE74490 0 V 1 TRIPTOLIDE MOUSE DN

A Gene Set from LINCS

GSE207499 sphingosine 1 v 0 human up

A Gene Set from LINCS

GSE155987 LMTK2 knockdown CFBE41o- 0 v 1 human dn

A Gene Set from LINCS

GSE158834 ADIPOR2 knockout HEK293 12 v 13 human up

A Gene Set from LINCS

GSE195663 cisplatin 0 v 1 human dn

A Gene Set from LINCS

GSE244730 erlotinib PC-9 0 v 1 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.